EAG Laboratories is expanding its medical device testing capabilities with a new 20,000 square-foot laboratory located in St. Louis, Mo.
The new laboratory is a bespoke design to support the requirements of the medical device industry. It increases EAG’s analytical capabilities, allows for improved turnaround times and helps meet evolving requirements from the FDA as well as the European Union Medical Device Regulations (MDR).
Specialty features of the laboratory include:
EAG scientists have been investigating and resolving product failures for more than half a century and have a deep understanding of materials and testing procedures. The medical device laboratory expansion allows EAG to leverage that knowledge and apply it toward supporting the growing and vitally important medical device industry.
The St. Louis laboratory is ISO 9001:2015 and ISO 17025 accredited; FDA-registered and DEA Licensed, and offers analytical support in terms of materials characterization, failure analysis, particle identification, contaminant identification, analyte quantitation, and ISO 10993-18 chemical characterization.
Learn about the important role of Glow Discharge Mass Spectrometry (GDMS) in preventing aerospace failures. Even the smallest impurities can cause catastrophic results.
The CHIPS and Science Act is investing to grow the semiconductor industry in the United States. EAG can help.
Discover the power of LiDAR technology behind the scenes. Learn about the role of SIMS in the world of LiDAR to reveal the chemical makeup of materials.
Join us for an engaging virtual info session titled “Cultivating Talent & Community,” hosted by EAG Laboratories in collaboration with our parent company, Eurofins Scientific.
To enable certain features and improve your experience with us, this site stores cookies on your computer. Please click Continue to provide your authorization and permanently remove this message.
To find out more, please see our privacy policy.